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2214-0247/Copyright ª 2015, TaiwanAbstract This study aimed to investigate the effects of electrical injury on vascular damage
and on matrix metalloproteinase (MMPs) levels. Thirty male Wistar albino rats were divided
into five groups (nZ 6), including a control group (untreated group), a 600 mv electrical burn
injury group, a 900 mv electrical burn injury group, a 1200 mv electrical burn injury group, and
a 1500 mv electrical burn injury group. Endothelial progenitor cells (EPCs) and circulating
endothelial cells (CECs) were analyzed using flow cytometry. The levels of MMP-9, MMP-3, ni-
tric oxide (NO), vascular endothelial growth factor (VEGF), and vascular cell adhesion mole-
cule (VCAM) were assayed using an enzyme linked immunosorbent assay. Levels of EPCs
were significantly lower in all electrical burn injury groups compared with the control group
(p < 0.05). The levels of NO and VEGF were significantly increased in all electrical burn injury
groups compared with the control group (p < 0.05). The levels of MMP-9 were significantly
higher in the 1200 mv electrical burn injury group compared with the control group or the
900 mv electrical burn injury group (p < 0.05). There were no significant differencesciences Doctoral Study Program, Faculty of Medicine, Brawijaya University, Jl. Veteran Malang 65145,
ail.com (D.P.T.R. Maluegha).
4.12.001
Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
EPCs in electrical burn 79in MMP-3, VCAM, and CECs levels between groups (p > 0.05). This electrical burn injury model
shows a significant decrease in endothelial progenitor cells and an increase in VEGF, NO, and
MMP-9 as the compensating mechanism.
Copyright ª 2015, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Electrical burns trauma is one of the most common injuries,
which occurs due to contact with live electric wires or
lightning equipment. Several factors are associated with
the degree of electrical injury, such as voltage and elec-
trical current, the site and duration of contact, body
resistance, and the access of the current flow through the
body.1e3 Early emergency medical treatment is required
after electrical trauma including prevention and supportive
treatment for infection of the burn wounds, muscle ne-
crosis, nausea, cardiac arrest or arrhythmia, pneumonia,
and vomiting.4,5
Circulating endothelial cells (CECs) are mature endo-
thelial cells that are detached from the endothelium and
circulate within peripheral blood. Several diseases are
associated with an increased number of CECs, such as
cardiovascular disease, vasculitis, infectious disease, and
cancers.6 Therefore, the level of CECs has been recognized
as a useful biomarker for vascular damage. When the
vascular damage increases, the compensating mechanisms
modulate the production of endothelial progenitor cells
(EPCs) from bone marrow. As far as we know, studies on
vascular damage from electrical injury remain limited.
After injury, an essential feature of wound healing is re-
epithelialization which depends on two basic functions of
keratinocytes: proliferation and migration.7 The re-
epithelialization process is influenced by a combination of
growth factors and cytokines including vascular endothelial
growth factor (VEGF).8 VEGF is one of the most potent
angiogenesis stimulating growth factors and functions as an
inducer of vascular permeability and for endothelial cell
mitogenic properties.9e11 Several reports show that VEGF
increases re-epithelialization in wound sites.12e14 Matrix
metalloproteases (MMPs) are enzymes for the breakdown of
extracellular matrix in tissue remodeling.15 Therefore, this
study aimed to investigate the effects of electrical injury
on vascular damage and its healing properties.Material and methods
Animal
Thirty male Wistar albino rats, 16-weeks old, weighing
160e200 g, were used for the present investigation. They
were housed in a clean wire cage and maintained under
standard laboratory conditions (temperature 25  2C with
a dark/light cycle of 12 hours/12 hours). They were fed a
standard pellet diet and received water ad libitum. The
animals were acclimatized to laboratory conditions for 1week prior to the experiment. The rats were divided into
five groups (n Z 6), including a control group (untreated
group), a 600 mv electrical burn injury group (EBI600), a
900 mv electrical burn injury group (EBI900), a 1200 mv
electrical burn injury group (EBI1200), and a 1500 mv elec-
trical burn injury group (EBI1500).Electrical burn injury
Rat models of electrical burns were made by providing
electricity in rats that had been anesthetized. Rats were
injected intraperitoneally with Ketalar (ketamine hydro-
chloride) 15 mg (100 mg/kg) that had been diluted with
saline. An anesthetized rat was put to sleep on its back on
the table applicator. The left front leg was coated with a
wet cloth clamped to an AC power flow as an inflow. The
right hind leg was coated with a wet cloth clamped to an AC
power as an outflow. Furthermore, the rat was given a
voltage of 600e1500 mV strong currents, 15 mA for 10
seconds.Analysis of MMP-3 and MMP-9 levels
The amount of MMP-3 and MMP-9 in serum was determined
using the human MMP-3 and MMP-9 Quantikine enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems,
Minneapolis, MN, USA) according to the manufacturer’s in-
structions. Optical density was read using a microplate
reader at 450 nm. The amount of MMP-3 and -9 (pg/mL) was
calculated from a standard curve. The sensitivity of this kit
was 5 pg/mL.Measurement of EPCs
EPCs were isolated from blood as described in previous
studies, with modification.16 Briefly, 3 mL of EDTA-blood
was obtained by means of cardiac puncture, stored at
4e10C, and processed within 6 hours after collection.
Mononuclear cells were isolated by density-gradient
centrifugation using 1.083 g/mL Ficoll-Paque at 1600 rpm,
20C, 30 minutes (Sigma-Aldrich Inc., Saint Louis, Missouri,
USA). Isolated cells were washed twice with phosphate
buffered saline (PBS) and resuspended in PBS supplemented
with 0.5% of bovine serum albumin and 2 mM of EDTA.
Double positive CD34þ and CD45þ cells were evaluated by
immunostaining with PE-conjugated CD34 monoclonal
antibody (BioLegend, San Diego, California, USA) and FITC-
45 conjugated CD34 monoclonal antibody (BioLegend, San
Diego, California, USA). This assay was performed using
80 D.P.T.R. Maluegha et al.flow cytometry (BD FACSCalibur Flow Cytometer; BD Bio-
sciences, San Jose, California, USA).Measurement of CECs
CECs were isolated from blood as described elsewhere16,
with modification. Briefly, 3 mL of EDTA-blood was obtained
by means of a cardiac puncture, stored at 4e10C, and
processed within 6 hours after collection. Mononuclear
cells were isolated by density-gradient centrifugation using
1.083 g/mL Ficoll-Paque (Sigma-Aldrich). Isolated cells
were washed twice with PBS and resuspended in PBS sup-
plemented with 0.5% of bovine serum albumin and 2 mM of
EDTA. Double positive VEGFRþ and CD146þ cells were
evaluated by immunostaining with FITC-conjugated CD146
monoclonal antibody and PE-conjugated VEGFR monoclonal
antibody (BioLegend) and detected using flow cytometry
(BD FACSCalibur Flow Cytometer).Analysis of VEGF and vascular cell adhesion protein
levels
The amount of VEGF and vascular cell adhesion protein
(VCAM) levels in the serum was determined using the
human VEGF (VEGF-A) and VCAM Quantikine ELISA kit
Catalogue number RRRRV00 (R&D Systems) according to the
manufacturer’s instructions. Optical density was read using
a microplate reader at 450 nm. The amount of VEGF and
VCAM (pg/mL) was calculated from a standard curve. The
sensitivity of this kit was 5 pg/mL.Analysis of nitric oxide levels
The amount of nitric oxide (NO) in the serum was deter-
mined using the human nitric oxide Quantikine ELISA kit
(R&D Systems) according to the manufacturer’s in-
structions. Optical density was read using a microplate
reader at 450 nm. The amount of NO (pg/mL) was calcu-
lated from a standard curve. The sensitivity of this kit was
5 pg/mL.Ethical approval
This research has been approved by the Research Ethics
Committee in the Faculty of Medicine University of Brawi-
jaya, Malang, Indonesia.Table 1 The levels of EPCs and CECs in electrical burn injury a
Levels (%) Control
600 mv 90
EPCs 9.842  6.653 0.600  0.120* 0.
CECs 0.345  0.286 0.025  0.023 0.
Note: values are presented as mean  SD.
*p < 0.05 in comparison with the control group.
**p < 0.05 in comparison with EBI600 group.
CECs Z circulating endothelial cells; EPCs Z endothelial progenitorStatistical analysis
Data are presented as mean  SD and differences between
groups were analyzed using 1-way analysis of variance
(ANOVA) with SPSS version 15.0 (SPSS Inc., Chicago, Illinois,
USA). Post hoc test was used if the ANOVA was significant. A
p value <0.05 was considered statistically significant.
Results
EPCs and CECs level
Levels of EPCs were significantly lower in all electrical burn
injury groups compared with the control group (p < 0.05;
Table 1). These levels were also significantly decreased in
EBI1200 compared with EBI600 (p < 0.05). The levels of CECs
were not significantly different between groups (p > 0.05).
NO, VEGF, and VCAM levels
The levels of NO and VEGF were significantly increased in
all electrical burn injury groups compared with the control
group (p < 0.05; Table 2). These two parametes levels were
also significantly higher in EBI1200 compared with EBI600
(p < 0.05). VEGF levels were significantly reduced in EBI1500
compared with EBI1200 (p < 0.05). There were no significant
differences in VCAM levels between groups (p > 0.05).
MMP-9 and MMP-3 levels
The levels of MMP-9 were significantly higher in EBI1200
compared with the control group or EBI900 (p < 0.05; Table
3). These levels were also significantly increased in EBI900,
EBI1200, and EBI1500 compared with EBI600 (p < 0.05). There
were no significant differences in MMP-3 levels between
groups (p > 0.05).
Discussion
The levels of CECs were not significantly different between
groups (p > 0.05). This finding indicated that this model of
electrical burn injury does not induce vascular damage.
VEGF is an endothelial cell-specific mitogen which pro-
motes the growth of vascular endothelial cells from the
arteries, veins, and lymphatics.15 VEGF is also a survival
factor for endothelial cells, as it prevents endothelial
apoptosis by mediating the phosphatidylinositol 3-kinasend control group.
Electrical burn injury (EBI)
0 mv 1200 mv 1500 mv
220  0.440* 0.142  0.285*,** 0.292  0.578*
280  0.540 0.005  0.005 0.022  0.026
cells.
Table 2 The levels of NO, VEGF, and VCAM in electrical burn injury and control groups.
Levels Control Electrical burn injury (EBI)
600 mv 900 mv 1200 mv 1500 mv
NO (pg/mL) 0.062  0.040 0.492  0.246* 1.427  0.940* 1.956  0.491*,** 1.563  0.820*
VEGF (pg/mL) 13.250  5.500 44.600  13.398* 60.400  11.391* 96.750  24.316*,**,*** 57.400  18.075*,****
VCAM (ng/mL) 4.497  5.893 0.402  0.751* 0.195  0.357 0.340  0.361 0.315  0.295
Data are presented as mean  SD.
*p < 0.05 in comparison with control group.
**p < 0.05 in comparison with EBI600 group.
***p < 0.05 in comparison with EBI900 group.
****p < 0.05 in comparison with EBI1200 group.
NO Z nitric oxide; VCAM Z vascular cells adhesion molecule; VEGF Z vascular endothelial growth factor.
Table 3 The levels of MMP-9 and -3 in electrical burn injury and control groups.
Levels (ng/mL) Control Electrical burn injury (EBI)
600 mv 900 mv 1200 mv 1500 mv
MMP-9 0.076  0.073 0.030  0.007 0.116  0.045** 0.231  0.020*,**,*** 0.171  0.072**
MMP-3 0.403  0.210 0.254  0.079 0.481  0.099 0.618  0.157 0.522  0.239
Data are presented as mean  SD.
*p < 0.05 in comparison with control group.
**p < 0.05 in comparison with EBI600 group.
***p < 0.05 in comparison with EBI900 group.
MMP Z matrix metalloproteinase.
EPCs in electrical burn 81(PI3K)/Akt pathway16 and induces expression of the anti-
apoptotic proteins Bcl-2, A1, XIAP, and survivin in endo-
thelial cells.17,18 We found that VEGF was significantly
increased in all electrical burn injury groups compared with
the control group (p < 0.05), but reduced in EBI1500
compared with EBI1200 (p < 0.05). This finding indicated
that in our model of electrical burn injury, VEGF acted to
prevent the endothelial damage. The peak levels of VEGF
and NO were achieved at 1200 mv, then the levels reduced
with the highest voltage. This peak indicated the maximal
response for angiogenesis or survival factor for endothelial
cells. We also hypothesized that NO acts as a molecular
signal for vascular healing by EPCs homing. Our study also
showed that the levels of EPCs were significantly lower in
all electrical burning injury groups compared with the
control group (p < 0.05). When we compared the levels of
VEGF and these two cell markers, our models showed that
VEGF acts as a survival factor for endothelial cells. This
means that this pathway determines the success of the
angiogenesis process as part of wound healing. Besides, the
endothelial progenitor cells were more sensitive to elec-
trical injury compared with mature endothelial cells. We
also found that the level of VCAM was lower in all treatment
groups compared with the control group, but reached sig-
nificant levels in the first dose group (p < 0.05). This finding
indicates that the adhesion molecules, which play major
roles in the leukocyte adhesion process, are downregulated
in our model. This response may be due to nuclear factor-
kB alteration in burn injury.19
The healing process of a burn consists of three phases:
inflammatory (from 3 hours to 1 day after the burn), pro-
liferative (from 1 day to 7 days), and maturation (from 7days to 14 days).20 In this study, treatment with electrical
burn injury (EBI1200) significantly increases the levels of
MMP-9 compared with the control group or EBI900
(p < 0.05). There were no significant differences in MMP-3
levels between groups (p > 0.05). This finding indicates
that our model for electrical burn injury at 1200 mv
significantly increased the MMP-9 expression that is
involved in the breakdown of extracellular matrix in tissue
remodeling. Our findings are consistent with a previous
study which showed that MMP-9 expression increased
throughout the three phases from 6 hours after the burn
injury.20 MMP-9 is usually secreted by macrophages in the
late proliferative to maturation phases of mechanically-
induced skin wounds, and remodels the granulation tissue
by degrading ECM.21,22 Burn blister fluid contains MMP-9,
released by neutrophils, as early as 4e8 hours after the
burn and MMP-9 degrades heat-denatured collagen in this
phase.23 Alteration of the MMP-9eTIMP-1 balance may in-
fluence systemic inflammatory response.24Conclusion
This model of electrical burn injury significantly reduces
EPCs. In order to maintain vascular integrity, VEGF, NO, and
MMP-9 have a role in a compensative mechanism.Conflicts of interest
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